InvestorsHub Logo

kund

12/28/23 2:42 PM

#444543 RE: Hoskuld #444541

Nope, schedule slip is common for the clown Misleading. All other bios are on target even if the trial failed, and no one is trying to hide data. Check ANVS, Bivi, SAVA, etc. They are managing trials and data release as per plan.

Misleading doesn't know the value of time; vague timelines and fumbling data release are what he is good at.

rx7171

12/28/23 4:17 PM

#444574 RE: Hoskuld #444541

Whenever you have many moving parts under different scientific and regulatory controls and individuals when any one can delay progress the more delays you should expect.

In Biotech the science, the money needs and regulatory agencies all have the power to delay, and why it usually takes about ten years from initiating a drug discovery program to approval.

With the vast majority never getting across the line including many with good potential that never get past the financial support barrier needed prior to any revenue.